Anteris Technologies: A Breakthrough in Heart Valve Innovation

Anteris Technologies Global Corp. (ASX: AVR) is a structural heart company focused on developing cutting-edge solutions for heart valve disease. Headquartered in Australia with operations in the U.S. and Europe, the company’s flagship product is the DurAVR® Transcatheter Heart Valve (THV), a first-of-its-kind biomimetic, balloon-expandable valve that mimics the natural human aortic valve. Recent one-year clinical data showed that DurAVR® delivered exceptional hemodynamic outcomes—sustaining effective orifice area, maintaining low pressure gradients, and crucially, achieving zero prosthesis-patient mismatch (PPM), a leading cause of valve failure. The system incorporates Anteris' proprietary ADAPT® anti-calcification tissue, used in over 55,000 patients globally. With a strong safety profile and high implant success, DurAVR® is set for pivotal trials and U.S. FDA IDE submission. Anteris continues to redefine treatment for aortic stenosis, offering renewed hope for patients with structural heart disease.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com